Results 311 to 320 of about 1,033,840 (396)

The Development and Challenges of PET/MRI Dual‐Modality Imaging Probes—An Update

Journal of Magnetic Resonance Imaging, EarlyView.
ABSTRACT The integration of Positron emission tomography (PET) with Magnetic resonance imaging (MRI) combines the functional imaging capabilities of PET with the high‐resolution anatomical detail of MRI, creating a synergistic platform for advanced diagnostic imaging and image‐guided therapies. Central to the success of this dual‐modality system is the
Maryam Sabbaghan, Saumya Nigam, Isabella Kasabasic, Medha Manepalli, Ping Wang, Jinda Fan   +5 more
wiley   +1 more source

Faculty Opinions recommendation of Elevated gene expression levels distinguish human from non-human primate brains.

, 2003
Austin L. Hughes
openalex   +1 more source

MR‐Guidance of Gene Therapy for Brain Diseases: Moving From Palliative Treatment to Cures

Journal of Magnetic Resonance Imaging, EarlyView.
ABSTRACT Regulatory bodies in the U.S. and Europe recently approved a gene therapy for aromatic L‐amino acid decarboxylase (AADC) deficiency, a rare neurologic disorder where a genetic mutation prevents dopamine production in the brain. Affected children fail to develop normal motor and cognitive functions.
Dalton H. Bermudez, Thomas Lilieholm, Walter F. Block   +2 more
wiley   +1 more source

Pulmonary delivery of an erythropoietin Fc fusion protein in non-human primates through an immunoglobulin transport pathway

, 2004
Alan J. Bitonti, Jennifer Dumont, Susan C. Low, Robert Peters, Keith E. Kropp, Vito J. Palombella, James M. Stattel, Yichun Lu, Cristina A. Tan, Jeffrey Song, Ana M. García, Neil E. Simister, Gerburg M. Spiekermann, Wayne I. Lencer, Richard S. Blumberg   +14 more
openalex   +1 more source

Aortic Function in a Longitudinal 4D Flow MRI Study in Marfan Syndrome Patients Receiving Resveratrol

Journal of Magnetic Resonance Imaging, EarlyView.
ABSTRACT Background New treatment strategies are required to reduce aortic events in Marfan syndrome (MFS). Resveratrol is a dietary supplement that intervenes in aortic wall cellular metabolism and may benefit MFS patients. Purpose To evaluate whether treatment with Resveratrol affects aorta hemodynamics derived from 4D flow MRI in MFS.
Daan Bosshardt, Mitzi M. van Andel, E. M. Schrauben, Roland R. J. van Kimmenade, Arthur J. Scholte, Moniek G. J. P. Cox, Daniëlle Robbers‐Visser, Aeilko H. Zwinderman, Barbara J. M. Mulder, Aart J. Nederveen, Vivian de Waard, Maarten Groenink, Pim van Ooij   +12 more
wiley   +1 more source

Non-human primate studies for cardiomyocyte transplantation-ready for translation? [PDF]

Front Pharmacol
von Bibra C, Hinkel R.
europepmc   +1 more source

Fist‐Palm Test May Identify Mild Cognitive Impairment and Freezing of Gait in Parkinson's Disease: A Machine Learning Approach

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Mild cognitive impairment (MCI) and freezing of gait (FOG) are two common symptoms in Parkinson's disease (PD). Objectives The objectives were to test the strength of association of fist‐palm test (FiPaT), a nonverbal motor test, with both MCI and FOG in PD and investigate the predictive ability of FiPaT in the identification of PD ...
Sofia Cuoco, Michela Russo, Carlo Ricciardi, Beatrice D'Arco, Cristiano Sorrentino, Arianna Cappiello, Maria Romano, Francesco Amato, Marco Aiello, Roberto Erro, Marianna Amboni, Paolo Barone   +11 more
wiley   +1 more source

A non-human primate combinatorial system for long-distance communication. [PDF]

iScience
Gallot Q, Depriester C, Moran S, Zuberbühler K.   +3 more
europepmc   +1 more source

Changes in Gait Speed Vary Widely after the Use of Antiparkinson Medication in Persons with Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Antiparkinson medications are effective in improving Parkinson's disease (PD) motor symptoms such as bradykinesia, tremor, and rigidity. The impact of antiparkinson medication on gait speed is less clear. Objectives The primary aim was to determine the effects of antiparkinson medication on gait speed in PD. The secondary aim was to
Anson B. Rosenfeldt, Cielita Lopez‐Lennon, Erin Suttman, Amy Elizabeth Jansen, Eric Zimmerman, Courtney Miller, Rachel Lovati, Hubert H. Fernandez, Peter B. Imrey, Leland E. Dibble, Jay L. Alberts   +10 more
wiley   +1 more source